ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Operating cash flow 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$46.0MFY2025 · since FY2017: -$34.9M → -$46.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.0M | +51.7% |
| FY2024 | -$95.2M | +39.1% |
| FY2023 | -$156.3M | +15.0% |
| FY2022 | -$183.9M | +4.6% |
| FY2021 | -$192.7M | -28.8% |
| FY2020 | -$149.7M | -172.9% |
| FY2019 | $205.4M | +736.7% |
| FY2018 | -$32.3M | +7.5% |
| FY2017 | -$34.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice